A ‘positive tau’ (at Creutzfeldt–Jakob disease cut-off >1300 pg/ml) was obtained in vascular dementia (7.8%), Alzheimer’s disease (7.6%), Parkinson’s disease (2.0%) and Lewy body disease (1.8%) (Table 4). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.